SAFETY AND TOLERABILITY OF ODM-201 IN PATIENTS WITH PROSTATE CANCER: EXTENSION STUDY TO STUDY 3104001

Mise à jour : Il y a 5 ans
Référence : EUCTR2010-022803-24

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective of this extension study is to gain more information about the long-term safety and tolerability of ODM-201.


Critère d'inclusion

  • Progressive castration resistant prostate cancer (MedDRA: hormone-refractory prostate cancer)